Meeting Banner
Abstract #0842

Evaluation of a New Multimodality Voxel-Based Imaging Biomarker for Therapeutic Response Assessment in GBM

Benjamin Lemasson1, Thomas Chenevert1, Theodore Lawrence2, Christina Tsien2, Pia Sundgren3, Charles Meyer1, 4, Larry Junck5, Jennifer Boes1, Jean-Christophe Brisset1, Stefanie Galbn2, Timothy Johnson6, Alnawaz Rehemtulla1, Brian Ross1, Craig Galbn1

1Radiology, University of Michigan, Ann Arbor, MI, United States; 2Radiation Oncology, University of Michigan, Ann Arbor, MI, United States; 3Radiology, University of Michigan, Ann arbor, MI, United States; 4Biomedical, University of Michigan, Ann Arbor, MI, United States; 5Neurology, University of Michigan, Ann Arbor, MI, United States; 6Biostatistics, University of Michigan, Ann Arbor, MI, United States

The purpose was to evaluate the diagnostic performance of MRI based T1 and rCBV maps analyzed using a new multi-parametric response map (mPRM) base on a voxel-based analysis for early chemoradiation response prediction in patients diagnosed with high-grade gliomas. The percentage change, PRM and mPRM techniques using T1 and rCBVmap were used to assessed tumor response 1 and 3 weeks mid-treatment of 23 patients bearing glioma. mPRMT1+/rCBV- significantly identified patients resistant irrespective of tumor volume delineation and the time point mid-treatment used. This new approach could become a powerful tool to analyze multiparametric and/or multimodal data.

Keywords

absolute acid acquisition administration adult advancements affine analyzed analyzing applied arbor assessed assessment attenuated automated biomedical biostatistics blood blue bolus brain briefly calculating cerebral characteristic clinical color combination combining common computed continue continues contoured contrast curves cutoff cutoffs decreasing defined delineation described detection determine determined determining diagnosed diagnostic dose dynamic early either enhanced evaluate evaluation even flair fluid form fractions fully gadolinium grade green improves included increasing initiation interval intravenous introduces irrespective jean late like malignancy manually mapping maps materials measured medical metrics modality month mutual neurology novel oncology operator optimal optimization overall parametric patient patients percentage performance plots population post predict prediction previously procedure promise prospective protocol quantitative radiation radiology rank receiver recovery recruited referred registered registration resistant respective response robust scanner schematic sensitive sensitivity serial significance significantly simplex specifically statistical statistics stratified summed survival susceptibility systems therapeutic therapy threshold timothy tool treatment trial tumor unchanged underwent volume week weeks